Biochemistry, Genetics and Molecular Biology
Gastric Inhibitory Polypeptide
85%
Insulin Release
49%
Glucagon-Like Peptide-1
48%
Glucagon
48%
Antidiabetic Activity
43%
Ob/Ob Mouse
41%
Glycation
36%
Receptor Antagonist
33%
Dipeptidyl Peptidase
30%
Glucagon Receptor
30%
Glucose Blood Level
27%
Biological Activity
27%
N-Terminus
26%
Cyclic Adenosine Monophosphate
23%
Blood Plasma
22%
Agonist
21%
Gastric Inhibitory Polypeptide Receptor
21%
Glucose Homeostasis
18%
Body Weight
16%
Sorbitol
15%
Secretion (Process)
15%
High-Performance Liquid Chromatography
13%
Insulin Blood Level
13%
Glucagon-Like Peptide 1 Receptor
12%
Peptide Sequence
12%
Cholecystokinin
11%
Animal Model
11%
Incretin
10%
Glucose Transport
10%
Insulin Resistance
9%
Enzyme
9%
Glucose Metabolism
9%
Mouse Mutant
8%
Anura
8%
Receptor Binding
8%
Alanine
8%
Insulin Sensitivity
8%
Palmitic Acid
8%
Enzymatic Degradation
7%
Arginine
7%
Apelin
7%
C-Peptide
6%
Hyperglycemia
6%
Mass Spectrometry
6%
Amino Acids
6%
Swiss Webster Mouse
6%
B Cell
6%
Neuropeptide
6%
Dogfish
5%
Proinsulin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Gastric Inhibitory Polypeptide
100%
Glucagon-Like Peptide-1
64%
Ob/Ob Mouse
43%
Non Insulin Dependent Diabetes Mellitus
41%
Dipeptidyl Peptidase IV
38%
Carboxamide
35%
Biological Activity
28%
Diabetic Obesity
27%
Gastric Inhibitory Polypeptide Receptor
25%
Glucagon Like Peptide 1 [7-36] Amide
21%
Apelin
19%
Receptor
18%
Protein Hydrolysate
17%
Diabetes Mellitus
17%
Receptor Antagonist
16%
Incretin
16%
Antidiabetic Agent
15%
Metformin
14%
Nateglinide
11%
Arginine
10%
Sorbitol
10%
Cyclic AMP
10%
Amino Acid
9%
Insulin Resistance
9%
Streptozotocin
8%
Anura
8%
Cholecystokinin Octapeptide
7%
Glucagon-Like Peptide 1 Receptor
7%
Glucose Intolerance
7%
Acetic Acid Derivative
7%
Radioimmunoassay
7%
Alanine
7%
Fatty Acid
6%
Neuromedin U
6%
Pelophylax ridibundus
6%
Glucagon
6%
Neuropeptide
6%
Peptide Fragment
6%
IC50
6%
Levo Glucose
5%
Pharmacological Activity
5%
Polypeptide
5%
Intraperitoneal Injection
5%
Electrospray Ionization
5%
Medicine and Dentistry
Gastric Inhibitory Polypeptide
59%
Diabetes
28%
Glucagon Like Peptide 1
28%
Maturity Onset Diabetes of the Young
25%
Beta Cell
19%
Biological Activity
16%
Insulin Release
16%
Antidiabetic Activity
14%
In Vitro
14%
Dipeptidyl Peptidase IV
13%
Receptor
12%
Glucose Tolerance
10%
Cyclic AMP
10%
Ob/Ob Mouse
9%
Glycon
9%
Carboxamide
9%
Streptozocin
9%
Glucagon
8%
Apelin
8%
Incretin
7%
Receptor Antagonist
7%
Alanine
7%
Secretion (Process)
7%
Insulin Resistance
7%
Protein Hydrolysate
7%
Food Intake
7%
Diabetic Obesity
7%
Glycation
6%
Antidiabetic Agent
5%
Glucose Metabolism
5%
Peptide Fragment
5%
Amino Terminal Sequence
5%
Diabetes Mellitus
5%
Physical Activity Level
5%
Glucagon Receptor Antagonist
5%
Glucose Uptake
5%
